Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 6 Apr 23 424B3 Prospectus supplement
- 6 Apr 23 EFFECT Notice of effectiveness
- 31 Mar 23 POS AM Prospectus update (post-effective amendment)
- 16 Mar 23 POS EX Additional exhibits for listing
- 16 Mar 23 424B3 Prospectus supplement
- 16 Mar 23 424B3 Prospectus supplement
- 9 Jan 23 424B3 Prospectus supplement
- 6 Jan 23 424B3 Prospectus supplement
- 28 Nov 22 EFFECT Notice of effectiveness
- 25 Nov 22 424B3 Prospectus supplement
-
10 Nov 22 F-1 Registration statement (foreign)
MDWD similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form F-1) and related Prospectus of MediWound Ltd. for the registration of common stock and to the incorporation by reference therein of our report, dated February 25, 2021, with respect to the consolidated financial statements of MediWound Ltd. included in its Annual Report (Form 20-F) for the year ended December 31, 2020, filed with the Securities and Exchange Commission.
/s/ KOST FORER GABBAY & KASIERER | |
November 10, 2022 | KOST FORER GABBAY & KASIERER |
Tel-Aviv, Israel | A Member of EY Global |